NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • Getting involved with research
    • Researcher Guidance
    • Post an opportunity for patient and public involvement
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Clinical Informatics and Big Data > Data reveals COVID-19 risk factors for people with type 1 diabetes

Data reveals COVID-19 risk factors for people with type 1 diabetes

11 May 2021 · Listed under Clinical Informatics and Big Data, COVID-19, Diabetes and Metabolism

The largest study of people with type 1 diabetes admitted to hospital with COVID-19 has found that those with higher body mass index (BMI), poorer kidney function and the presence of microvascular complications were at greater risk of death and/or admission to intensive care.

Adonagonzalez via Pixabay

However, the study, supported by the NIHR Oxford Biomedical Research Centre, also found that risk of severe COVID-19 was very low in people with type 1 diabetes who are under 55 years of age without microvascular or macrovascular disease.

This national audit, which began in September 2020, is a collaborative project with the Association of British Clinical Diabetologists (ABCD) that has brought together clinical researchers from 40 NHS centres with data scientists and informaticians at Oxford University Hospitals (OUH) NHS Foundation Trust and the University of Oxford.

Anonymised data on more than 3,300 people admitted with both diabetes and COVID from across the UK were transferred to the National Institute for Health Research (NIHR) Health Informatics Collaborative (HIC) Coordinating Centre at OUH, where they were entered into a novel database and analysed.

The researchers found that there was a 27% mortality in the almost 200 people with type 1 diabetes who were entered into the database.

In contrast, there was no mortality among patients with type 1 diabetes under 55 years old and with no complications from their diabetes.

The study was published as an open access paper in the journal Diabetologia.

The lead author, OUH diabetes consultant Dr Rustam Rea, said: “We wanted to identify the risk factors associated with severe COVID-19 among adults with type 1 diabetes, and analysis of the data has shown that BMI, poor renal function and having one or more microvascular complications were associated with poorer outcomes – death or admission to ICU.

“What was reassuring was that there were no deaths among people under the age of 55 without complications relating to their diabetes.” 

He added: “We’d like to thank the 40 NHS centres that contributed important data to this study. The resulting database is a unique resource that is supporting a range of different analyses and revealing important insights into the effects of COVID-19 and related treatments for people with diabetes. We expect to publish more findings from this collaborative project in the coming months.”

← Study highlights role of BMI in increased COVID-19 risks
Oxford BRC researchers named among new Academy of Medical Sciences fellows →

News

  • Lymph nodes reveal more about mechanisms of autoimmunity 14 June 2022
  • Conference aims to forge collaborations to tackle dementia 9 June 2022
  • Lung function device wins top chemistry Prize 8 June 2022
See full news archive

News Categories

Month Archives

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2022 NIHR Oxford Biomedical Research Centre